森下仁丹の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/01/20 | 1,902 | 1,902 | 1,901 | 1,901 | -1 | -0.1% | 500 |
| 2023/01/19 | 1,901 | 1,903 | 1,901 | 1,902 | +1 | +0.1% | 500 |
| 2023/01/18 | 1,903 | 1,910 | 1,901 | 1,901 | -9 | -0.5% | 900 |
| 2023/01/17 | 1,904 | 1,910 | 1,904 | 1,910 | +6 | +0.3% | 300 |
| 2023/01/16 | 1,903 | 1,913 | 1,901 | 1,904 | +1 | +0.1% | 1,200 |
| 2023/01/13 | 1,914 | 1,915 | 1,902 | 1,903 | +2 | +0.1% | 600 |
| 2023/01/12 | 1,914 | 1,914 | 1,901 | 1,901 | +4 | +0.2% | 300 |
| 2023/01/11 | 1,900 | 1,900 | 1,897 | 1,897 | -3 | -0.2% | 400 |
| 2023/01/10 | 1,910 | 1,918 | 1,900 | 1,900 | -18 | -0.9% | 1,800 |
| 2023/01/06 | 1,902 | 1,918 | 1,902 | 1,918 | ±0 | ±0% | 300 |
| 2023/01/05 | 1,910 | 1,918 | 1,910 | 1,918 | +25 | +1.3% | 300 |
| 2023/01/04 | 1,896 | 1,897 | 1,893 | 1,893 | -3 | -0.2% | 1,000 |
| 2022/12/30 | 1,900 | 1,900 | 1,896 | 1,896 | -2 | -0.1% | 500 |
| 2022/12/29 | 1,899 | 1,899 | 1,898 | 1,898 | -2 | -0.1% | 200 |
| 2022/12/28 | 1,898 | 1,900 | 1,892 | 1,900 | +2 | +0.1% | 3,000 |
| 2022/12/27 | 1,890 | 1,898 | 1,890 | 1,898 | +8 | +0.4% | 1,100 |
| 2022/12/26 | 1,900 | 1,900 | 1,889 | 1,890 | -4 | -0.2% | 1,800 |
| 2022/12/23 | 1,886 | 1,897 | 1,886 | 1,894 | +4 | +0.2% | 2,000 |
| 2022/12/22 | 1,894 | 1,894 | 1,890 | 1,890 | -3 | -0.2% | 900 |
| 2022/12/21 | 1,894 | 1,894 | 1,887 | 1,893 | -2 | -0.1% | 3,100 |
| 2022/12/20 | 1,906 | 1,906 | 1,895 | 1,895 | -12 | -0.6% | 1,200 |
| 2022/12/19 | 1,906 | 1,907 | 1,892 | 1,907 | -1 | -0.1% | 2,800 |
| 2022/12/16 | 1,900 | 1,908 | 1,900 | 1,908 | +8 | +0.4% | 900 |
| 2022/12/15 | 1,902 | 1,910 | 1,900 | 1,900 | -2 | -0.1% | 1,400 |
| 2022/12/14 | 1,902 | 1,902 | 1,902 | 1,902 | ±0 | ±0% | 300 |
| 2022/12/13 | 1,900 | 1,905 | 1,900 | 1,902 | ±0 | ±0% | 1,900 |
| 2022/12/12 | 1,902 | 1,903 | 1,900 | 1,902 | -1 | -0.1% | 2,900 |
| 2022/12/09 | 1,907 | 1,909 | 1,903 | 1,903 | -14 | -0.7% | 800 |
| 2022/12/08 | 1,909 | 1,917 | 1,902 | 1,917 | +8 | +0.4% | 300 |
| 2022/12/07 | 1,904 | 1,909 | 1,903 | 1,909 | +5 | +0.3% | 1,100 |
| 2022/12/06 | 1,905 | 1,905 | 1,904 | 1,904 | -1 | -0.1% | 400 |
| 2022/12/05 | 1,908 | 1,908 | 1,905 | 1,905 | -3 | -0.2% | 600 |
| 2022/12/02 | 1,911 | 1,911 | 1,907 | 1,908 | -3 | -0.2% | 400 |
| 2022/12/01 | 1,912 | 1,916 | 1,911 | 1,911 | -5 | -0.3% | 500 |
| 2022/11/30 | 1,908 | 1,929 | 1,906 | 1,916 | -8 | -0.4% | 1,800 |
| 2022/11/29 | 1,924 | 1,924 | 1,924 | 1,924 | +20 | +1.1% | 100 |
| 2022/11/28 | 1,919 | 1,919 | 1,904 | 1,904 | -12 | -0.6% | 400 |
| 2022/11/25 | 1,917 | 1,917 | 1,904 | 1,916 | +6 | +0.3% | 1,300 |
| 2022/11/24 | 1,906 | 1,910 | 1,904 | 1,910 | +4 | +0.2% | 1,100 |
| 2022/11/22 | 1,902 | 1,906 | 1,902 | 1,906 | -5 | -0.3% | 500 |
| 2022/11/21 | 1,919 | 1,919 | 1,911 | 1,911 | -1 | -0.1% | 500 |
| 2022/11/18 | 1,910 | 1,912 | 1,910 | 1,912 | -8 | -0.4% | 500 |
| 2022/11/17 | 1,918 | 1,921 | 1,911 | 1,920 | +10 | +0.5% | 500 |
| 2022/11/16 | 1,911 | 1,911 | 1,910 | 1,910 | -6 | -0.3% | 800 |
| 2022/11/15 | 1,910 | 1,916 | 1,910 | 1,916 | -9 | -0.5% | 1,200 |
| 2022/11/14 | 1,921 | 1,925 | 1,913 | 1,925 | +13 | +0.7% | 900 |
| 2022/11/11 | 1,925 | 1,925 | 1,910 | 1,912 | +1 | +0.1% | 1,500 |
| 2022/11/10 | 1,955 | 1,955 | 1,911 | 1,911 | -18 | -0.9% | 3,300 |
| 2022/11/09 | 1,926 | 1,929 | 1,910 | 1,929 | +8 | +0.4% | 4,400 |
| 2022/11/08 | 1,910 | 1,987 | 1,907 | 1,921 | +8 | +0.4% | 7,100 |
551～
600
件表示中 / 3683件
類似銘柄と比較する
現在ご覧いただいている「仁 丹」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 仁 丹 | 208,500円 | +2.4% | +10.4% | 2.64% | 12.19倍 | 0.68倍 |
|
代名詞の仁丹から整腸作用軸に健康サプリ、医薬品へ展開。シームレスカプセル技術に特長 |
| ＮＡＮＯ | 13,500円 | -20.0% | - | 0.00% | - | 3.13倍 |
|
ｍＲＮＡ医薬品に特化した創薬ベンチャー。創薬シーズ発掘から非臨床開発まで手がけて導出 |
| カイオム | 13,500円 | +92.3% | - | 0.00% | - | 4.79倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
| サイフューズ | 103,900円 | +459.3% | - | 0.00% | - | 3.41倍 |
|
バイオ３Ｄプリンタを開発、自家細胞製品の製造受託も。臓器など再生医療等製品を臨床開発中 |
| ラクオリア | 35,700円 | +25.1% | - | 0.00% | - | 1.41倍 |
|
ファイザー旧国内研究所が前身。導出消化器薬の海外売上が拡大、収益柱に。低分子創薬に強い |
市場注目の銘柄
チャート関連のコラム
